ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Plans Phase-Out Of K04 Career Awards

March 3, 1995

Sandra Swain at ASCO 2013: Let’s Focus on Three Goals

June 7, 2013

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

May 28, 1999

Rogers Reaffirms Congress’ Interest In Cancer Program; Act Renewal To “Broaden, Sustain It”

April 14, 1978

Clinical Trials Approved By NCI

October 31, 2003

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004